Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?
NRXS is benefiting from stronger IB-Stim volumes, broader reimbursement and VA access, but incomplete payer coverage and cash needs remain challenges.
Zacks
More News
Is Kodak having a "Kodak moment?" 2 watchlist stocks.
KODK and NRXS are worth watching for their growth.
Zacks
NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up
NeurAxis delivers record second-quarter 2026 revenues as stronger IB-Stim demand, higher pricing and an improved reimbursement mix lift gross margin.
Zacks
NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y
NRXS' first-quarter 2026 results show surging revenue and expanding gross margin as reimbursement improves under the Category I CPT code.
Zacks
The Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxis
Alphabet, Walmart and Micron lead Zacks research as AI growth, retail strength and memory demand drive performance, while risks linger.
Zacks
Top Stock Reports for Alphabet, Walmart & Micron
Alphabet rides AI-driven growth across Search, Cloud and subscriptions, but rising spending, debt and legal risks temper near-term flexibility.
Zacks
NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth
NRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization investments weigh on profitability.
Zacks
The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis
Meta Platforms leads today???s Zacks Research Daily as AI-driven engagement and ad demand fuel growth, even as heavy AI investments raise monetization concerns.
Zacks
Top Stock Reports for Meta, Bank of America & Procter & Gamble
Meta Platforms leads today's Zacks Research Daily as analysts highlight strong user growth, heavier AI investment and lingering concerns around monetization.
Zacks
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth
NeurAxis posts its fifth straight quarter of double-digit expansion, but rising costs and margin pressure weigh on third-quarter 2025 results.